Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210834
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2005-09-13
Brief Title:
An Efficacy and Safety Study of Epoetin Alfa PROCRIT Initiated at 40000 Units Every Week Versus 80000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy
Sponsor:
Organization:
Johnson Johnson Pharmaceutical Research Development LLC